Pounder R E, Williams J G, Milton-Thompson G J, Misiewicz J J
Gut. 1976 Feb;17(2):133-8. doi: 10.1136/gut.17.2.133.
The effect of H2-receptor blockade on intragastric acidity was studied in nine normal males. The pH of their gastric contents was measured at hourly daytime and two hourly nighttime intervals for 48 hours. The subjects ate identical meals, drank identical volumes of fluid, and smoked the same number of cigarettes during the two study days. Their physical activity was unrestricted in a ward environment. Blood cimetidine and plasma gastrin were measured in serial blood samples. The nine subjects were treated in random sequence with cimetidine 0-8-1-0 g on one day and placebo capsules on the other. The drug was given in four divided doses: four subjects received it before, and five after, the three main meals. All took the fourth dose at bedtime. Replicate studies in an additional subject given placebo on both study days showed good reproducibility (r=0-80, P less than 0-01). Cimetidine therapy decreased intragastric acidity in all nine subjects. The decrease was similar in the two groups taking the drug before or after meals, mean 24 h intragastric hydrogen ion activity being lowered by 70 and 72% respectively. Nocturnal anacidity was recorded in only two of 45 samples. Administration of cimetidine before meals produced earlier and higher drug blood levels than post-prandial medication, but when it was taken after food the blood levels were highest at the time when the buffer capacity of the food was waning. Blood concentrations of cimetidine exceeded the secretory IC50 level for most of the time between doses. The results show that cimetidine 0-8-1-0 g/day in four divided doses produces a striking and consistent decrease of intragastric acidity. Although variation in the timing of the dose in relation to meals did not affect the decrease of acidity, the absorption data suggest that patients should take the drug after meals.
对9名正常男性研究了H2受体阻滞剂对胃内酸度的影响。在48小时内,白天每小时、夜间每两小时测量他们胃内容物的pH值。在两个研究日期间,受试者进食相同的餐食,饮用相同量的液体,且吸烟数量相同。他们在病房环境中的身体活动不受限制。在连续采集的血样中测量血西咪替丁和血浆胃泌素水平。9名受试者按随机顺序,一天服用0.8-1.0g西咪替丁,另一天服用安慰剂胶囊。药物分四次服用:四名受试者在三餐前服用,五名受试者在三餐后服用。所有人在睡前服用第四剂。在两个研究日都给予安慰剂的另一名受试者进行的重复研究显示出良好的可重复性(r=0.80,P<0.01)。西咪替丁治疗使所有9名受试者的胃内酸度降低。在饭前或饭后服用药物的两组中,酸度降低情况相似,平均24小时胃内氢离子活性分别降低70%和72%。在45个样本中,只有2个记录到夜间无酸。饭前服用西咪替丁比餐后服药产生的药物血药浓度更早且更高,但在进食后服用时,血药浓度在食物缓冲能力减弱时最高。西咪替丁的血药浓度在两次给药之间的大部分时间都超过了分泌IC50水平。结果表明,每日0.8-1.0g分四次服用的西咪替丁可使胃内酸度显著且持续降低。虽然给药时间与进餐时间的差异不影响酸度降低,但吸收数据表明患者应在饭后服药。